The origins of autism remain mysterious. What areas of the brain are involved, and when do the first signs appear? New findings published in Biological Psychiatry bring us closer to understanding...
In separate clinical trials, a drug called ocrelizumab has been shown to reduce new attacks in patients with relapsing remitting multiple sclerosis (MS), and new symptom progression in primary...
A new outdoor laboratory will serve as a facility for studying the effects on our lakes of climate change and chemicals commonly used in Quebec. It features a series of 96 experimental ponds...
By Tod Hoffman, Lady Davis Institute
Research reveals that even a tiny mutation can allow the HIV virus to become resistant to therapies using the CRISPR/Cas9 gene-editing platform